Inventor
JAGODZINSKA BARBARA
US16 patents
⚠️ This page may combine multiple inventors who share the name “JAGODZINSKA BARBARA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ELAN PHARM INC
6 patentsUS7727997B2Jun 1, 2010
N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
ELAN PHARM INC21 citations89
US7214715B2May 8, 2007
Compounds to treat Alzheimer's disease
ELAN PHARM INC18 citations83
US7294642B2Nov 13, 2007
1,3-Diamino-2-hydroxypropane pro-drug derivatives
ELAN PHARM INC8 citations74
US7858642B2Dec 28, 2010
Substituted hydroxyethylamine aspartyl protease inhibitors
ELAN PHARM INC5 citations60
US7385085B2Jun 10, 2008
Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
ELAN PHARM INC6 citations60
US7906556B2Mar 15, 2011
Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
ELAN PHARM INC0 citations37
UPJOHN CO
4 patentsUS7176242B2Feb 13, 2007
N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
UPJOHN CO92 citations95
US6962934B2Nov 8, 2005
Substituted amino carboxamides for the treatment of Alzheimer's disease
UPJOHN CO19 citations83
US6846813B2Jan 25, 2005
Compounds to treat alzheimer's disease
UPJOHN CO10 citations73
US7338965B2Mar 4, 2008
3,4-disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines
UPJOHN CO4 citations62
UNIV CALIFORNIA
3 patentsUS11142505B2Oct 12, 2021
Compositions for APP-selective BACE inhibition and uses therefor
UNIV CALIFORNIA0 citations59
US12441716B2Oct 14, 2025
Compositions and methods for increasing muscle mass and oxidative metabolism
UNIV CALIFORNIA0 citations54
US11077108B2Aug 3, 2021
Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition
UNIV CALIFORNIA0 citations49